There is no evidence that Angioprim works. Chelation therapy as a treatment for cardiovascular disease has not been proven to be effective and carries significant risk.
Angioprim claims to be an oral chelation therapy. Medical trials of chelation therapy as a treatment for cardiovascular disease have been inconclusive. Chelation therapy has not been accepted by the medical community and has not been approved by the U.S. Food and Drug Administration as a treatment for any condition other than heavy metal poisoning. Even under direct medical supervision, chelation therapy carries significant risk. It can cause liver and kidney damage and hypocalcemia, which can lead to death. Patients have died while undergoing medically supervised chelation therapy.